TCERG1

Across TCGA pan-cancer cohorts, TCERG1 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated TCERG1 data layer compared with 28 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher TCERG1 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated TCERG1 expression acts as an unfavorable survival marker, although some lineages such as GBM and LSCC show a favorable association.

HNSC, GBM, and LSCC are the cancer types where TCERG1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Quartile	All	0.786	0.981	<.001	40	view →
GBM	DFS	Median	All	0.338	0.200	.015	4	view →
LSCC	DFS	Tertile	II,III,IV	1.000	0.902	.025	4	view →
CCRCC	DFS	Median	IV	0.781	0.220	.017	3	view →
LUAD	DFS	Median	III,IV	0.432	0.925	.047	3	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

TCERG1–HNSC (OS)

Open the HNSC breakdown →